Search by Drug Name or NDC
NDC 36800-0525-10 Headache Relief 250; 250; 65 mg/1; mg/1; mg/1 Details
Headache Relief 250; 250; 65 mg/1; mg/1; mg/1
Headache Relief is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by TOP CARE (Topco Associates LLC). The primary component is ACETAMINOPHEN; ASPIRIN; CAFFEINE.
Product Information
| NDC | 36800-0525 |
|---|---|
| Product ID | 36800-525_a40e239e-8b06-4e21-b1f2-f32fe118a188 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Headache Relief |
| Proprietary Name Suffix | Extra Strength |
| Non-Proprietary Name | Acetaminophen, Aspirin, Caffeine |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 250; 250; 65 |
| Active Ingredient Units | mg/1; mg/1; mg/1 |
| Substance Name | ACETAMINOPHEN; ASPIRIN; CAFFEINE |
| Labeler Name | TOP CARE (Topco Associates LLC) |
| Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [E |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH NOT FINAL |
| Application Number | part343 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 36800-0525-10 (36800052510)
| NDC Package Code | 36800-525-10 |
|---|---|
| Billing NDC | 36800052510 |
| Package | 1 BOTTLE, PLASTIC in 1 BOX (36800-525-10) / 100 TABLET in 1 BOTTLE, PLASTIC |
| Marketing Start Date | 2016-07-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |